Longitudinal Multimodal Profiling of Balance and Gait In Stroke
1 other identifier
observational
30
1 country
1
Brief Summary
Balance and gait recovery is a critical aspect of post-stroke motor rehabilitation. Researchers have effectively utilized EEG to investigate different aspects of lower limb motor control, however there are several technical challenges in the existing brain computer interface (BCI) motor profiling. The study aims to test the EEG-BCI system to see if it's effective in understanding the balance and walking patterns of post-stroke populations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2023
CompletedFirst Posted
Study publicly available on registry
January 2, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedApril 11, 2025
April 1, 2025
1.3 years
December 4, 2023
April 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
EEG Activities
To record EEG and EOG data from 64-Ch ActiCap EEG cap and electrode
Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)
Goniometers
7 sensors to measure 2-axis joint angles at bilateral Hip, Knee and Ankle
Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)
Secondary Outcomes (5)
Fugl Meyer Assessment for Lower Limbs
Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)
Berg Balance Scale
Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)
Modified Clinical Test for Sensory Interaction in Balance
Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)
10-metre Walk Test
Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)
6-minute Walk Test
Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)
Interventions
Assessments and questionnaires to quantify cortical and motor activities using portable EEG and lower limb sensors during dynamic balance and gait activities.
Eligibility Criteria
Patients in outpatient clinics
You may qualify if:
- First-ever clinical stroke (ischaemic or haemorrhagic) confirmed by admitting doctors brain imaging
- Age 21 to 85 years
- At least ≥ 30 days post-stroke
- Gait impairments related to stroke
- Functional ambulation category -6 levels (Mehrholz et al, 2007): FAC ≥ 4, i.e. able to ambulate independently on level surface but requires supervision to negotiate (e.g. stairs, inclines, non-level surfaces).
- Montreal Cognitive Assessment (MoCA) score \> 21 (Nasreddine et al., 2005)
- Able to understand study instructions and requirements
You may not qualify if:
- Non-stroke related causes of gait impairment
- Medical conditions incompatible with research participation: uncontrolled medical illnesses (hypertension or diabetes, ischaemic heart disease, congestive heart failure, bronchial asthma, severe /untreated depression, agitation, end stage renal/liver/heart/lung failure, dialysis, unresolved cancers e.g.,), active seizures within 3 months
- Anticipated life expectancy of \< 6 months
- On subcutaneous or oral anti-coagulation
- Local factors potentially worsened by gait training: joint and muscle pains
- Lower limb pain VAS \>4/10, active lower limb fractures or arthritis, fixed leg contractures, severe peripheral vascular disease, organomegaly or aortic aneurysms
- Active unhealed skin wounds or inflammatory skin conditions over trunk and lower limbs,
- Severe visual impairment or visual neglect affecting navigation
- Known allergy to EEG gel (Recoverix)
- Presence of craniectomy skull defect
- Resident of nursing home or overseas country which may compromise attendance at research site
- Pregnant or lactating females
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tan Tock Seng Hospitallead
- Nanyang Technological Universitycollaborator
Study Sites (1)
Tan Tock Seng Hospital
Singapore, Singapore, Singapore
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dr Wee Seng Kwee
Tan Tock Seng Hospital
- PRINCIPAL INVESTIGATOR
Dr Karen Chua
Tan Tock Seng Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2023
First Posted
January 2, 2024
Study Start
July 1, 2024
Primary Completion
October 1, 2025
Study Completion
October 1, 2025
Last Updated
April 11, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share